Skip to main content

Table 1 Demographic and clinical characteristics of early-stage NSCLC patients and healthy controls

From: Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer

 

Training set

Validation set

NSCLC (n = 25)

Healthy (n = 25)

P -value

NSCLC (n = 126)

NCPD (n = 42)

Healthy (n = 60)

P -value

Age

       

≤ 60

14

13

0.777

79

26

35

0.847

>60

11

12

 

47

16

25

 

Sex

       

Male

15

12

0.395

87

29

36

0.443

Female

10

13

 

39

13

24

 

Smoking status

       

Current

9

7

0.807

54

21

17

0.004

Former

13

14

 

35

13

11

 

Never

3

4

 

37

8

32

 

TNM stage

       

Stage I

9

-

-

54

-

-

-

Stage II

16

-

 

72

-

-

 

Histological type

       

Adenocarcinoma

8

-

-

45

-

-

-

Squamous carcinoma

13

-

 

64

-

-

 

Others

4

-

 

17

-

-

 
  1. NSCLC, non-small cell lung cancer; NCPD, non-cancerous pulmonary disease.
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us